Alcon AG | ALC - Selling And Administration Expenses

Stock Price
64.26
Daily Change
0.48 0.75%
Monthly
2.55%
Yearly
-19.84%
Q1 Forecast
62.72

Alcon AG reported $865M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
AstraZeneca USD 4.61B 4.46B Dec/2025
Bayer EUR 3.4B 140M Sep/2025
Essilor EUR 5.62B 4.53B Dec/2025
Fresenius EUR 676M 64M Sep/2025
Fresenius Medical Care EUR 785M 79.56M Dec/2025
GlaxoSmithKline GBP 2.68B 518M Dec/2025
GRIFOLS EUR 284.99M 2.24M Sep/2025
Merck EUR 1.46B 16M Sep/2025
Novartis USD 3.31B 134M Sep/2025
Philips EUR 1.31B 127M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
Smith & Nephew USD 1.42B 65M Dec/2025
Sonova Holding CHF 880.2M 300K Jun/2025
UCB EUR 1.29B 221M Dec/2024